|Articles|July 7, 2004

Alcon updates NDA; FDA approves wider treatment range

Alcon, over a 2-day span in late June, filed one new drug application (NDA) with the FDA and received approval for another.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME